Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | -1.57% | -0.28% | -20.72% |
May. 15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
May. 09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.72% | 79.17M | |
+33.51% | 49.46B | |
+1.78% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.66% | 26.61B | |
-22.09% | 18.64B | |
+7.89% | 13.16B | |
+29.51% | 12.55B | |
+23.56% | 12.1B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- Wedbush Lowers Rallybio's PT to $11 From $13 After Private Placement, Adjusts Full-Year 2024 Share Count; Maintains Outperform Rating